The following is an excerpt from Reuters. A tangle of high-stakes U.S. patent disputes over Covid-19 vaccines could be tamed by court rulings or grow even more complex next year. In the headlining fight, Moderna sued Pfizer and BioNTech in August, accusing […]
Covid-19 vaccine patent battles continue into 2023 Read More »
The watchdog group Judicial Watch has received 699 pages of records from the Department of Health and Human Services (HHS) regarding data vaccine maker Moderna submitted to the Food and Drug Administration (FDA) on the company’s mRNA Covid-19 vaccine. The records indicate a
The following is an excerpt from Paul D. Thacker’s latest article in his Substack newsletter: The DisInformation Chronicle. “Weber Shandwick Provides PR for Moderna and Pfizer, While Staffing the CDC’s Vaccine Office.” In an odd case of synchronicity—and let’s be
(READ) Moderna and Pfizer PR firm housed in CDC vaccine offices Read More »
The following is an excerpt from Becker’s Hospital Review. Moderna and Merck entered an agreement Oct. 12 to develop, manufacture and sell personalized cancer vaccine candidates. The two drugmakers have been collaborators since 2016, but under the amended agreement, Merck will pay
Moderna, Merck join forces to develop cancer vaccine Read More »
This analysis found there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination The State Surgeon General now recommends against the COVID-19 mRNA vaccines for males ages
The following is an excerpt from Just The News. The mRNA Covid-19 vaccines made by Pfizer and Moderna showed no reduction in all-cause mortality in randomized controlled trials (RCTs), according to a new paper by researchers at primarily Danish institutions.
Study: Pfizer, Moderna Covid vaccines don’t reduce ‘all-cause’ deaths Read More »
The following is an excerpt from Becker’s Healthcare Hospital Review. Immunology experts have not concluded that more COVID-19 boosters are necessary despite Pfizer and Moderna’s efforts to promote the shots, Kaiser Health News reported March 21. On March 13, Pfizer CEO Albert
Experts: skeptical of more Covid-19 boosters despite drugmakers’ efforts Read More »
The following is an excerpt from MedPage. Moderna’s two-dose Covid-19 vaccine regimen for the youngest children was safe and met its primary immunogenicity endpoint, the manufacturer announced on Wednesday. An interim analysis of the phase II/III KidCOVE study found that two
Moderna to seek FDA authorization for lower-dose Covid-19 vaccine for children under 6 Read More »
